Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma
- 1 March 2019
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 109, 137-153
Abstract
No abstract availableKeywords
Funding Information
- Deutsche ForschungsgemeinschaftDeutsche Forschungsgemeinschaft (DFG, German Research Foundation) (RO3577/3-2, GRK1739/2)
- Hiege Foundation
- Monika-Kutzner Foundation
- German Cancer Aid (DKH-111886, DKH-70112257)
This publication has 43 references indexed in Scilit:
- Phenformin enhances the therapeutic benefit of BRAF V600E inhibition in melanomaProceedings of the National Academy of Sciences, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescenceProceedings of the National Academy of Sciences, 2012
- Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032Radiotherapy and Oncology, 2011
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- The Histone Demethylase KDM5b/JARID1b Plays a Role in Cell Fate Decisions by Blocking Terminal DifferentiationMolecular and Cellular Biology, 2008
- Demethylation of Histone H3K36 and H3K9 by Rph1: a Vestige of an H3K9 Methylation System in Saccharomyces cerevisiae?Molecular and Cellular Biology, 2007
- Re-Expression of the Retinoblastoma-Binding Protein 2-Homolog 1 Reveals Tumor-Suppressive Functions in Highly Metastatic Melanoma CellsJournal of Investigative Dermatology, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003